|
Realtime-Estimate
Cboe BZX
16:49:06 30.09.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 1.035 USD | -5.91% |
|
-11.11% | -80.63% |
| 23.09. | Compass-Therapeutics-Aktie rutscht nach Herabstufung durch Wedbush ab | MT |
| 23.09. | Compass Therapeutics, Inc. : Von Wedbush auf neutral herabgestuft | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -5.91% | -11.11% | -56.49% | -52.51% | -80.63% | -70.29% | -46.11% | -69.50% | - | 198 Mio. | |
| -0.70% | -4.28% | +2.07% | +27.34% | +77.25% | +52.62% | +86.42% | +7.04% | - | 71.53 Mrd. | |
| -0.52% | +0.98% | -3.61% | +4.02% | +17.75% | +36.75% | +80.73% | +225.24% | +5’416.34% | 60.12 Mrd. | |
| -1.18% | +2.42% | -0.21% | +5.42% | +6.99% | +9.14% | +36.84% | -17.99% | +210.02% | 48.85 Mrd. | |
| +0.71% | +1.11% | +3.69% | +40.17% | +20.15% | +42.59% | +39.69% | +13.06% | +234.12% | 44.28 Mrd. | |
| +1.56% | +8.24% | +0.43% | +10.24% | +159.21% | +342.10% | +688.92% | +650.49% | - | 43.83 Mrd. | |
| +1.84% | +1.77% | +3.30% | +30.35% | +22.27% | +9.03% | +108.10% | +2.33% | +1’105.63% | 41.53 Mrd. | |
| +0.34% | +0.22% | -6.19% | -0.17% | +3.78% | +5.18% | +47.36% | -16.63% | +135.73% | 30.13 Mrd. | |
| +4.77% | +6.16% | +14.76% | +61.99% | +78.28% | +36.77% | +26.10% | -55.69% | - | 27.98 Mrd. | |
| -1.07% | -3.70% | -6.45% | +6.88% | -34.52% | -20.87% | +349.19% | +313.80% | +684.85% | 25.25 Mrd. | |
| -0.66% | -0.82% | -3.90% | +4.94% | +2.57% | -0.98% | -13.39% | -64.23% | - | 24.76 Mrd. | |
| +1.53% | +2.44% | +10.65% | +30.81% | +15.84% | +21.82% | -3.93% | -16.41% | +107.79% | 20.99 Mrd. | |
| -0.33% | -0.42% | +3.46% | +16.04% | +9.42% | +19.53% | +153.36% | +224.68% | +1’958.14% | 17.36 Mrd. | |
| +3.46% | +3.02% | -22.65% | +4.38% | +182.04% | +158.90% | +337.81% | +1’394.96% | +639.22% | 15.54 Mrd. | |
| -1.08% | -0.89% | +4.05% | +10.09% | +20.96% | +22.18% | +44.21% | -31.90% | +86.67% | 14.99 Mrd. | |
| -0.39% | +1.96% | -13.51% | -14.71% | - | - | - | - | - | 14.98 Mrd. | |
| +1.31% | +9.20% | +32.65% | +44.37% | +41.63% | +3.62% | - | - | - | 14.9 Mrd. | |
| +1.50% | +4.25% | +8.24% | +8.69% | +34.93% | +43.20% | +166.16% | +179.75% | +362.39% | 14.53 Mrd. | |
| +2.96% | +0.83% | -2.05% | +11.65% | +24.17% | -5.25% | +519.59% | - | - | 14.41 Mrd. | |
| +0.01% | +6.50% | +2.47% | +30.23% | +48.06% | +88.77% | +52.72% | -28.43% | +254.39% | 14.13 Mrd. | |
| Durchschnitt | +0.42% | -0.46% | -1.46% | +14.01% | +34.22% | +41.83% | +148.54% | +159.45% | +932.94% | 28.01 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.52% | -0.07% | +1.07% | +18.33% | +42.18% | +54.56% | +149.03% | +142.59% | +1’351.50% |
- Börse
- Aktien
- A2QF3P Aktie
- Sektor Compass Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
